Cord blood transplantation in children with hemoglobinopathies

Bibliography

• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86(6):480-7
   PubMed Web of Science ®Google Scholar
• Johnson FL, Look AT, Gockerman J, et al. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984;311(12):780-3
   PubMed Web of Science ®Google Scholar
• Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassaemia. Lancet 1982;2(8292):227-9
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Piras E, Vacca A, et al. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood 2012;120(2):473-6
   PubMed Web of Science ®Google Scholar
• Locatelli F, Kabbara N, Ruggeri A, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013;122(6):1072-8
   PubMed Web of Science ®Google Scholar
• Lawson SE, Roberts IA, Amrolia P, et al. Bone marrow transplantation for beta-thalassaemia major: the UK experience in two paediatric centres. Br J Haematol 2003;120(2):289-95
   PubMed Web of Science ®Google Scholar
• Hussein AA, Al-Zaben A, Ghatasheh L, et al. Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. Pediatr Blood Cancer 2013;60(8):1345-9
   PubMed Web of Science ®Google Scholar
• Di Bartolomeo P, Santarone S, Di Bartolomeo E, et al. Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation. Am J Hematol 2008;83(7):528-30
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007;110(7):2749-56
   PubMed Web of Science ®Google Scholar
• Dedeken L, Le PQ, Azzi N, et al. Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol 2014;165(3):402-8
   PubMed Web of Science ®Google Scholar
• Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009;361(24):2309-17
   PubMed Web of Science ®Google Scholar
• Panepinto JA, Walters MC, Carreras J, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007;137(5):479-85
   PubMed Web of Science ®Google Scholar
• Vermylen C, Cornu G, Ferster A, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998;22(1):1-6
   PubMed Web of Science ®Google Scholar
• Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996;335(6):369-76
   PubMed Web of Science ®Google Scholar
• Pennings G, Schots R, Liebaers I. Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling. Hum Reprod 2002;17(3):534-8
   PubMed Web of Science ®Google Scholar
• Jawdat DM, Al Saleh S, Sutton P, et al. Chances of finding an HLA-matched sibling: The Saudi experience. Biol Blood Marrow Transplant 2009;15(10):1342-4
   PubMed Web of Science ®Google Scholar
• Mentzer WC, Heller S, Pearle PR, et al. Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol 1994;16(1):27-9
   PubMedGoogle Scholar
• Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003;101(11):4233-44
   PubMed Web of Science ®Google Scholar
• Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008;41(2):207-14
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JEJr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources. N Engl J Med 2000;342(25):1846-54
   PubMed Web of Science ®Google Scholar
• Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999;27(9):1418-27
   PubMed Web of Science ®Google Scholar
• Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997;89(11):3919-24
   PubMed Web of Science ®Google Scholar
• Tanavde VM, Malehorn MT, Lumkul R, et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002;30(7):816-23
   PubMed Web of Science ®Google Scholar
• Lu L, Xiao M, Shen RN, et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993;81(1):41-8
   PubMed Web of Science ®Google Scholar
• Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998;16(3):153-65
   PubMed Web of Science ®Google Scholar
• de Wynter EA, Emmerson AJ, Testa NG. Properties of peripheral blood and cord blood stem cells. Baillieres Best Pract Res Clin Haematol 1999;12(1-2):1-17
   PubMed Web of Science ®Google Scholar
• Leung W, Ramirez M, Novelli EM, Civin CI. In vivo engraftment potential of clinical hematopoietic grafts. J Investig Med 1998;46(6):303-11
   PubMed Web of Science ®Google Scholar
• Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci U S A 1992;89(21):10006-10
   PubMed Web of Science ®Google Scholar
• Cairo MS. Therapeutic implications of dysregulated colony-stimulating factor expression in neonates. Blood 1993;82(8):2269-72
   PubMed Web of Science ®Google Scholar
• Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994;154(1):14-24
   PubMed Web of Science ®Google Scholar
• Issaragrisil S, Visuthisakchai S, Suvatte V, et al. Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med 1995;332(6):367-9
   PubMed Web of Science ®Google Scholar
• Brichard B, Vermylen C, Ninane J, Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 1996;128(2):241-3
   PubMed Web of Science ®Google Scholar
• Miniero R, Rocha V, Saracco P, et al. Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. Bone Marrow Transplant 1998;22(Suppl 1):S78-9
   PubMed Web of Science ®Google Scholar
• Lau YL, Ma ES, Ha SY, et al. Sibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin, and review of the literature. J Pediatr Hematol Oncol 1998;20(5):477-81
   PubMed Web of Science ®Google Scholar
• Hongeng S, Pakakasama S, Hathirat P, et al. Mismatched related cord blood transplantation in a severe thalassemia patient. Bone Marrow Transplant 2000;25(12):1322-3
   PubMed Web of Science ®Google Scholar
• Goussetis E, Peristeri J, Kitra V, et al. Combined umbilical cord blood and bone marrow transplantation in the treatment of beta-thalassemia major. Pediatr Hematol Oncol 2000;17(4):307-14
   PubMed Web of Science ®Google Scholar
• Gore L, Lane PA, Quinones RR, Giller RH. Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care. J Pediatr Hematol Oncol 2000;22(5):437-40
   PubMed Web of Science ®Google Scholar
• Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101(6):2137-43
   PubMed Web of Science ®Google Scholar
• Walters MC, Quirolo L, Trachtenberg ET, et al. Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci 2005;1054:206-13
   PubMed Web of Science ®Google Scholar
• Soni S, Boulad F, Cowan MJ, et al. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies. Pediatr Blood Cancer 2014;61(9):1690-4
   PubMed Web of Science ®Google Scholar
• Tucunduva L, Volt F, Cunha R, et al. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases. Br J Haematol 2015;169(1):103-10
   PubMed Web of Science ®Google Scholar
• Fang J, Huang S, Chen C, Zhou D. Unrelated umbilical cord blood transplant for beta-thalassemia major. J Trop Pediatr 2003;49(2):71-3
   PubMed Web of Science ®Google Scholar
• Ruggeri A, Eapen M, Scaravadou A, et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011;17(9):1375-82
   PubMed Web of Science ®Google Scholar
• Jaing TH, Hung IJ, Yang CP, et al. Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients. Bone Marrow Transplant 2012;47(1):33-9
   PubMed Web of Science ®Google Scholar
• Kamani NR, Walters MC, Carter S, et al. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant 2012;18(8):1265-72
   PubMed Web of Science ®Google Scholar
• Adamkiewicz TV, Szabolcs P, Haight A, et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant 2007;11(6):641-4
   PubMed Web of Science ®Google Scholar
• Bank A, Dorazio R, Leboulch P. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann N Y Acad Sci 2005;1054:308-16
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010;467(7313):318-22
   PubMed Web of Science ®Google Scholar
• Cavazzana M, Ribeil JA, Payen E, et al. Study Hgb-205: outcomes of gene therapy for hemoglobinopathies via transplantation of autologous hematopoietic stem cells transduced ex vivo with a Lentiviral beta(A-T87Q)-Globin Vector (LentiGlobin (R) BB305 Drug Product). Blood 2014;124(21):4797
   Google Scholar
• Wilber A, Hargrove PW, Kim YS, et al. Therapeutic levels of fetal hemoglobin in erythroid progeny of beta-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Blood 2011;117(10):2817-26
   PubMed Web of Science ®Google Scholar
• Perumbeti A, Higashimoto T, Urbinati F, et al. A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction. Blood 2009;114(6):1174-85
   PubMed Web of Science ®Google Scholar
• Samakoglu S, Lisowski L, Budak-Alpdogan T, et al. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol 2006;24(1):89-94
   PubMed Web of Science ®Google Scholar
• Wilber A, Tschulena U, Hargrove PW, et al. A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. Blood 2010;115(15):3033-41
   PubMed Web of Science ®Google Scholar
• Gluckman E. Milestones in umbilical cord blood transplantation. Blood Rev 2011;25(6):255-9
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344(24):1870-1
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105(3):1343-7
   PubMed Web of Science ®Google Scholar
• Kwon M, Bautista G, Balsalobre P, et al. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant 2014;20(12):2015-22
   PubMed Web of Science ®Google Scholar
• Liu H, Rich ES, Godley L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood 2011;118(24):6438-45
   PubMed Web of Science ®Google Scholar
• Kim DW, Chung YJ, Kim TG, et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004;103(5):1941-8
   PubMed Web of Science ®Google Scholar
• Frassoni F, Gualandi F, Podesta M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008;9(9):831-9
   PubMed Web of Science ®Google Scholar
• Delaney C, Heimfeld S, Brashem-Stein C, et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010;16(2):232-6
   PubMed Web of Science ®Google Scholar
• de Lima M, McNiece I, Robinson SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 2012;367(24):2305-15
   PubMed Web of Science ®Google Scholar
• Horwitz ME, Chao NJ, Rizzieri DA, et al. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest 2014;124(7):3121-8
   PubMed Web of Science ®Google Scholar
• Stiff PJ, Montesinos P, Peled T, et al. StemEx (R) (Copper Chelation Based) ex vivo expanded umbilical cord blood stem cell transplantation (UCBT) accelerates engraftment and improves 100 day survival in myeloablated patients compared to a registry cohort undergoing double unit UCBT: results of a multicenter study of 101 patients with hematologic malignancies. Blood 2013;122(21):3060
   Google Scholar
• Wagner JE, Brunstein C, McKenna D, et al. Acceleration of umbilical cord blood (UCB) stem engraftment: results of a phase i clinical trial with stemregenin-1 (SR1) expansion culture. Biol Blood Marrow Transplant 2015;21(2):S48-9
   Web of Science ®Google Scholar
• Cutler C, Multani P, Robbins D, et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 2013;122(17):3074-81
   PubMed Web of Science ®Google Scholar
• Robinson SN, Simmons PJ, Thomas MW, et al. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2R gamma(null) mice. Exp Hematol 2012;40(6):445-56
   PubMed Web of Science ®Google Scholar
• Kahraman S, Beyazyurek C, Yesilipek MA, et al. Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. Reprod Biomed Online 2014;29(3):340-51
   PubMed Web of Science ®Google Scholar
• Kuliev A, Pakhalchuk T, Verlinsky O, Rechitsky S. Preimplantation genetic diagnosis for hemoglobinopathies. Hemoglobin 2011;35(5-6):547-55
   PubMed Web of Science ®Google Scholar
• Kabbara N, Locatelli F, Rocha V, et al. A multicentric comparative analysis of outcomes of HLA identical related cord blood and bone marrow transplantation in patients with beta-thalassemia or sickle cell disease. Bone Marrow Transplant 2008;41:S29-9
   Web of Science ®Google Scholar
• Fang J, Huang S, Chen C, et al. Umbilical cord blood transplantation in Chinese children with beta-thalassemia. J Pediatr Hematol Oncol 2004;26(3):185-9
   PubMed Web of Science ®Google Scholar
• Tan PL, Shek PC, Lim LC, et al. Umibilical cord blood stem cell from unrelated donors is a feasible alternate stem cell source for transplant in patients with genetic diseases. Ann Acad Med Singapore 2004;33(5 Suppl):S82-3
   PubMedGoogle Scholar
• Hall JG, Martin PL, Wood S, Kurtzberg J. Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol 2004;26(6):382-5
   PubMed Web of Science ®Google Scholar
• Jaing TH, Hung IJ, Yang CP, et al. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant 2005;11(5):349-53
   PubMed Web of Science ®Google Scholar
• Jaing TH, Yang CP, Hung IJ, et al. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 2007;40(4):307-11
   PubMed Web of Science ®Google Scholar
• Bradley MB, Satwani P, Baldinger L, et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant 2007;40(7):621-31
   PubMed Web of Science ®Google Scholar
• Jaing TH, Chen SH, Tsai MH, et al. Transplantation of unrelated donor umbilical cord blood for nonmalignant diseases: a single institution’s experience with 45 patients. Biol Blood Marrow Transplant 2010;16(1):102-7
   PubMed Web of Science ®Google Scholar
• Soni S, Breslin N, Cheerva A. Successful unrelated umbilical cord blood transplantation for class 3 beta-thalassemia major using a reduced-toxicity regimen. Pediatr Transplant 2014;18(2):E41-3
   PubMed Web of Science ®Google Scholar
• Parikh SH, Mendizabal A, Benjamin CL, et al. A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant 2014;20(3):326-36
   PubMed Web of Science ®Google Scholar
• Shah SA, Shah KM, Patel KA, et al. Unrelated Umbilical Cord Blood Transplant for Children with beta-Thalassemia Major. Indian J Hematol Blood Transfus 2015;31(1):9-13
   PubMed Web of Science ®Google Scholar
• Mazur M, Kurtzberg J, Halperin E, et al. Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. J Pediatr Hematol Oncol 2006;28(12):840-4
   PubMed Web of Science ®Google Scholar